Profil
Martin Ewart Johnson is currently a Senior Director-Director at hVIVO Ltd.
and a Director at The British Pain Society.
Previously, he worked as a Senior Director-Medical at hVIVO Ltd.
from 2012 to 2017 and as the Chief Medical Officer at hVIVO PLC.
Aktive Positionen von Martin Ewart Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
| HVIVO PLC | Corporate Officer/Principal | - |
The British Pain Society
 The British Pain Society Miscellaneous Commercial ServicesCommercial Services The British Pain Society operates as a multidisciplinary professional organization in the field of pain. It produces contemporary guidance, supported by available evidence on clinical and other pain matters. The company was Incorporated on November 29, 1979 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martin Ewart Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| HVIVO PLC | Corporate Officer/Principal | 01.05.2017 |
| HVIVO PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HVIVO PLC | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
The British Pain Society
The British Pain Society Miscellaneous Commercial ServicesCommercial Services The British Pain Society operates as a multidisciplinary professional organization in the field of pain. It produces contemporary guidance, supported by available evidence on clinical and other pain matters. The company was Incorporated on November 29, 1979 and is headquartered in London, the United Kingdom. | Commercial Services |
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
